Alternative Treatment Options to ALK Inhibitor Monotherapy for EML4-ALK-Driven Lung Cancer

MLA

Savvas Papageorgiou, et al. “Alternative Treatment Options to ALK Inhibitor Monotherapy for EML4-ALK-Driven Lung Cancer.” Cancers, vol. 14, July 2022, p. 3452. EBSCOhost, https://doi.org/10.3390/cancers14143452.

APA

Savvas Papageorgiou, Sarah L. Pashley, Laura O’Regan, Sam Khan, Richard Bayliss, & Andrew M. Fry. (2022). Alternative Treatment Options to ALK Inhibitor Monotherapy for EML4-ALK-Driven Lung Cancer. Cancers, 14, 3452. https://doi.org/10.3390/cancers14143452

Chicago

Savvas Papageorgiou, Sarah L. Pashley, Laura O’Regan, Sam Khan, Richard Bayliss, and Andrew M. Fry. 2022. “Alternative Treatment Options to ALK Inhibitor Monotherapy for EML4-ALK-Driven Lung Cancer.” Cancers 14 (July): 3452. doi:10.3390/cancers14143452.